Using stringent statistics, we found CSF of two cytokines in CSF are significantly higher in MS patients compared to that in controls (MIP-1α, 2.57-fold, and IP-10, 1.91-fold, respectively) (Supplementary Figure S2). This evidence concerns the gene CCL3 and myeloid sarcoma.